Am J Physiol Cell Physiol Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 279: C248-C256, 2000;
0363-6143/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (73)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, L. H.
Right arrow Articles by Ignarro, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, L. H.
Right arrow Articles by Ignarro, L. J.
Vol. 279, Issue 1, C248-C256, July 2000

IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells

Liu Hua Wei1, Aaron T. Jacobs1, Sidney M. Morris Jr.2, and Louis J. Ignarro1

1 Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California 90095; and 2 Department of Biochemistry and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania 15261

The objectives of this study were to determine whether rat aortic smooth muscle cells (RASMC) express arginase and to elucidate the possible mechanisms involved in the regulation of arginase expression. The results show that RASMC contain basal arginase I (AI) activity, which is significantly enhanced by stimulating the cells with either interleukin (IL)-4 or IL-13, but arginase II (AII) expression was not detected under any condition studied here. We further investigated the signal transduction pathways responsible for AI induction. AI mRNA and protein levels were enhanced by addition of forskolin (1 µM) and inhibited by H-89 (30 µM), suggesting positive regulation of AI by a protein kinase A pathway. Genistein (10 µg/ml) and sodium orthovanadate (Na3VO4; 10 µM) were used to investigate the role of tyrosine phosphorylation in the control of AI expression. Genistein inhibited, whereas Na3VO4 enhanced the induction of AI by IL-4 or IL-13. Along with immunoprecipitation and immunoblot analyses, these data implicate the JAK/STAT6 pathway in AI regulation. Dexamethasone (Dex) and interferon (IFN)-gamma were investigated for their effects on AI induction. Dex (1 µM) and IFN-gamma (100 U/ml) alone had no effect on basal AI expression in RASMC, but both reduced AI induction by IL-4 and IL-13. In combination, Dex and IFN-gamma abolished AI induction by IL-4 and IL-13. Finally, both IL-4 and IL-13 significantly increased RASMC DNA synthesis as monitored by [3H]thymidine incorporation, demonstrating that upregulation of AI is correlated with an increase in cell proliferation. Blockade of AI induction by IFN-gamma , H-89, or genistein also blocked the increase in cell proliferation. These observations are consistent with the possibility that upregulation of AI might play an important role in the pathophysiology of vascular disorders characterized by excessive smooth muscle growth.

interleukin; rat aortic smooth muscle cells; cell proliferation; cytokines


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
L. Santhanam, D. W. Christianson, D. Nyhan, and D. E. Berkowitz
Arginase and vascular aging
J Appl Physiol, November 1, 2008; 105(5): 1632 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
L. H. Wei, Y. Yang, G. Wu, and L. J. Ignarro
IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1198 - C1205.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
J. Dumont, M. Zureik, D. Cottel, M. Montaye, P. Ducimetiere, P. Amouyel, and T. Brousseau
Association of arginase 1 gene polymorphisms with the risk of myocardial infarction and common carotid intima media thickness
J. Med. Genet., August 1, 2007; 44(8): 526 - 531.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
N. Thengchaisri, T. W. Hein, W. Wang, X. Xu, Z. Li, T. W. Fossum, and L. Kuo
Upregulation of Arginase by H2O2 Impairs Endothelium-Dependent Nitric Oxide-Mediated Dilation of Coronary Arterioles
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2035 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Erdely, D. Kepka-Lenhart, M. Clark, P. Zeidler-Erdely, M. Poljakovic, W. J. Calhoun, and S. M. Morris Jr
Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L534 - L539.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
G. S. Getz and C. A. Reardon
Arginine/Arginase NO NO NO
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 237 - 239.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. Teupser, R. Burkhardt, W. Wilfert, I. Haffner, K. Nebendahl, and J. Thiery
Identification of Macrophage Arginase I as a New Candidate Gene of Atherosclerosis Resistance
Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 365 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Sinha, V. K. Clements, and S. Ostrand-Rosenberg
Interleukin-13-regulated M2 Macrophages in Combination with Myeloid Suppressor Cells Block Immune Surveillance against Metastasis
Cancer Res., December 15, 2005; 65(24): 11743 - 11751.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. K. Johnson, R. A. Johnson, K. J. Peyton, and W. Durante
Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1057 - R1062.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Sinha, V. K. Clements, and S. Ostrand-Rosenberg
Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease
J. Immunol., January 15, 2005; 174(2): 636 - 645.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Zhang, T. W. Hein, W. Wang, M. W. Miller, T. W. Fossum, M. M. McDonald, J. D. Humphrey, and L. Kuo
Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide-Mediated Dilation of Coronary Arterioles
Hypertension, December 1, 2004; 44(6): 935 - 943.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
N. E. King, M. E. Rothenberg, and N. Zimmermann
Arginine in Asthma and Lung Inflammation
J. Nutr., October 1, 2004; 134(10): 2830S - 2836S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. P. Aoki, N. L. Guinazu, A. V. Pellegrini, T. Gotoh, D. T. Masih, and S. Gea
Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes
Am J Physiol Cell Physiol, February 1, 2004; 286(2): C206 - C212.
[Abstract] [Full Text]

Home page
 Physiol. Rev.Home page
G. E. Mann, D. L. Yudilevich, and L. Sobrevia
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Physiol Rev, January 1, 2003; 83(1): 183 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. M. Walter, J. J. McIntire, G. Berry, A. N. J. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu
Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
J. Immunol., October 15, 2001; 167(8): 4668 - 4675.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
M. Yang, S. P. Hogan, P. J. Henry, K. I. Matthaei, A. N. J. McKenzie, I. G. Young, M. E. Rothenberg, and P. S. Foster
Interleukin-13 Mediates Airways Hyperreactivity through the IL-4 Receptor-Alpha Chain and STAT-6 Independently of IL-5 and Eotaxin
Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 522 - 530.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Kepka-Lenhart, S. K. Mistry, G. Wu, and S. M. Morris Jr.
Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages?
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2237 - R2242.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. J. Ignarro, G. M. Buga, L. H. Wei, P. M. Bauer, G. Wu, and P. del Soldato
Inaugural Article: Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation
PNAS, March 27, 2001; 98(7): 4202 - 4208.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. H. Wei, G. Wu, S. M. Morris Jr., and L. J. Ignarro
Elevated arginase I expression in rat aortic smooth muscle cells increases cell proliferation
PNAS, July 31, 2001; 98(16): 9260 - 9264.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
P. M. Bauer, G. M. Buga, and L. J. Ignarro
Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide
PNAS, October 23, 2001; 98(22): 12802 - 12807.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online